MurD enzymes from different bacteria: evaluation of inhibitors

Hélène Barreteau1, Izidor Sosič, Samo Turk

  • 1Univ Paris-Sud, Laboratoire des Enveloppes Bactériennes et Antibiotiques, UMR 8619, Orsay, F-91405, France.

Insights

Antibacterial drug discovery targeting bacterial D-glutamic acid-adding enzyme (MurD ligase) showed varied efficacy. Most inhibitors effective against E. coli MurD were less potent against orthologues from other bacteria due to active site differences.

Area of Science:

  • Biochemistry
  • Microbiology
  • Drug Discovery

Background:

  • D-Glutamic acid-adding enzyme (MurD ligase) is crucial for bacterial cell-wall peptidoglycan synthesis.
  • MurD ligase is a significant target for developing novel antibacterial agents.
  • Previous research identified inhibitors for Escherichia coli MurD with IC50 values as low as 8 μM.

Purpose of the Study:

  • To evaluate the efficacy of known Escherichia coli MurD inhibitors against MurD enzymes from other bacterial species.
  • To investigate the potential for broad-spectrum antibacterial activity of these inhibitors.
  • To understand the structural basis for differential inhibition of MurD orthologues.

Main Methods:

  • In vitro biochemical assays were used to test the inhibitory activity of 20 selected compounds.
  • The compounds were tested against purified MurD ligase enzymes from Staphylococcus aureus, Streptococcus pneumoniae, Borrelia burgdorferi, and Mycobacterium tuberculosis.
  • Enzyme inhibition was quantified using IC50 values.

Main Results:

  • Most tested compounds showed reduced inhibitory efficiency against the MurD enzymes from Staphylococcus aureus, Streptococcus pneumoniae, Borrelia burgdorferi, and Mycobacterium tuberculosis compared to Escherichia coli.
  • Significant variations in IC50 values were observed across different bacterial orthologues.
  • The observed differences in inhibitor potency correlate with variations in the amino acid sequences and active site structures of the MurD ligases.

Conclusions:

  • The efficacy of MurD inhibitors is species-specific, limiting their potential as broad-spectrum antibacterial agents.
  • Structural differences in the active sites of MurD ligases from various bacteria contribute to differential drug responses.
  • Further research is needed to develop MurD inhibitors with broader antibacterial coverage or to design targeted therapies for specific pathogens.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...